Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing

Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing

CaaMTech aims to take the uncertainty out of psychedelics like magic mushrooms and to provide defined formulations. (BigStock photo) CaaMTech, a Seattle-area startup developing new psychedelic agents, has raised $ …

Read more